PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
176.45 - 178.59
86.62 - 184.48
124.91M / 173.95M (Avg.)
50.81 | 3.50
Helps investors judge whether earnings growth is driven by sustainable operations or temporary factors. Consistent, organic income expansion can justify a higher intrinsic value for patient, long-term investors.
0.71%
Revenue growth below 50% of MRVL's 13.58%. Michael Burry would check for competitive disadvantage risks.
-1.79%
Cost reduction while MRVL shows 12.30% growth. Joel Greenblatt would examine competitive advantage.
8.96%
Gross profit growth 50-75% of MRVL's 14.70%. Martin Whitman would scrutinize competitive position.
8.19%
Margin expansion exceeding 1.5x MRVL's 0.99%. David Dodd would verify competitive advantages.
0.96%
R&D growth less than half of MRVL's 15.53%. David Dodd would verify if efficiency advantage is sustainable.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
1574.30%
Other expenses growth above 1.5x MRVL's 7.48%. Michael Burry would check for concerning trends.
69.97%
Operating expenses growth above 1.5x MRVL's 9.61%. Michael Burry would check for inefficiency.
14.08%
Total costs growth 1.25-1.5x MRVL's 10.78%. Martin Whitman would scrutinize control.
No Data
No Data available this quarter, please select a different quarter.
14.91%
D&A growth above 1.5x MRVL's 3.03%. Michael Burry would check for excessive investment.
-650.53%
EBITDA decline while MRVL shows 16.77% growth. Joel Greenblatt would examine position.
36.88%
EBITDA margin growth exceeding 1.5x MRVL's 10.93%. David Dodd would verify competitive advantages.
-912.75%
Operating income decline while MRVL shows 25.23% growth. Joel Greenblatt would examine position.
-907.05%
Operating margin decline while MRVL shows 34.17% growth. Joel Greenblatt would examine position.
9.70%
Other expenses growth while MRVL reduces costs. John Neff would investigate differences.
-748.05%
Pre-tax income decline while MRVL shows 28.55% growth. Joel Greenblatt would examine position.
-743.50%
Pre-tax margin decline while MRVL shows 37.09% growth. Joel Greenblatt would examine position.
-165.30%
Tax expense reduction while MRVL shows 23.98% growth. Joel Greenblatt would examine advantage.
-1025.69%
Net income decline while MRVL shows 17.65% growth. Joel Greenblatt would examine position.
-1019.20%
Net margin decline while MRVL shows 27.49% growth. Joel Greenblatt would examine position.
-966.67%
EPS decline while MRVL shows 17.86% growth. Joel Greenblatt would examine position.
-966.67%
Diluted EPS decline while MRVL shows 17.86% growth. Joel Greenblatt would examine position.
0.68%
Share count reduction below 50% of MRVL's 0.58%. Michael Burry would check for concerns.
-9.15%
Diluted share reduction while MRVL shows 0.58% change. Joel Greenblatt would examine strategy.